magnifying glass
logo for Apollon Formularies

Apollon Formularies

Get Full Access

Who is Apollon Formularies

Apollon Formularies is an international bio-medical pharmaceutical company specialising in cutting edge research and treatment of patients with cancer and chronic pain. Apollon is federally legal, licensed in Jamaica, holds a suite of licences which allow the company to work with full spectrum oils inclusive of high levels of THC. Apollon's formulations are available by prescription to any licensed Jamaican doctor for their patients and for export to any country allowing legal import.Read More

Headquarters

Headquarters:

Westmoreland, Jamaica
Employees

Employees:

<25
Apollon Formularies's Social Media
SIC Code 2834,283
NAICS Code 32541,325
Popular Searches:

Apollon Formularies

Apollon Formularies plc

Apollon Formularies , plc

Apollon Formularies , plc.

Apollon Formularies plc.

Apollon Formularies's Org Chart

Stephen Barnhill
Stephen Barnhill

Chairman & Chief Executive Officer

PhonePhoneEmailEmail
Matthew Allpass
Matthew Allpass

Chief Innovation Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Apollon Formularies's Tech Stack

Twitter for Websites

By

Twitter

Twitter Embedded Timelines

By

Twitter

Microsoft Exchange Online

By

Microsoft

Google Cloud Web Serving

By

Google
See more technologies

Apollon Formularies News & Media

Apollon Formularies Establishes Joint Venture with Tri-Medi Canna, South Africa

LONDON, March 2, 2022 /PRNewswire/ -- Apollon Formularies plc (AQSE: APOL), a UK based international pharmaceutical company, is pleased to announce that it has signed a Joint Venture Agreement with Tri-Medi Canna Pty, a South African based medical cannabis company, to establish a...

Apollon Formularies' Grand Opening of International Cancer and Chronic Pain Institute

LONDON, Feb. 3, 2022 /PRNewswire/ -- Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on the Aquis Stock Exchange Growth Market, is pleased to announce that it has officially opened its International...

Apollon Formularies Announces Appointment of Dr. Herbert Fritsche, Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas to the Board of Directors

Dr. Fritsche is the Chief Science Officer of Apollon Formularies Jamaica Ltd (Non-Executive Director) LONDON, Jan. 27, 2022 /PRNewswire/ -- Apollon Formularies plc (AQSE: APOL) ("Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE...
Subscribe to "Apollon Formularies" News

Frequently Asked Questions regarding Apollon Formularies

Where are Apollon Formularies’s headquarters?

Apollon Formularies’s headquarters are in Westmoreland, Jamaica

What is Apollon Formularies’s official website?

Apollon Formularies’s official website is www.apollon.org.uk

What is Apollon Formularies’s SIC code?

Apollon Formularies’s SIC: 2834,283

What is Apollon Formularies’s NAICS code?

Apollon Formularies’s NAICS: 32541,325

How many employees are working in Apollon Formularies?

Apollon Formularies has <25 employees

What is Apollon Formularies’s industry?

Apollon Formularies is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

What is Apollon Formularies's tech stack?

The technologies that are used by Apollon Formularies are: Twitter for Websites, Twitter Embedded Timelines, Microsoft Exchange Online, Google Cloud Web Serving

Who is Apollon Formularies's CEO?

Apollon Formularies's CEO is Stephen Barnhill

See more information about Apollon Formularies
4.4/5 on G2 Crowd